Nanobac Pharmaceuticals Inc (NNBP)
0.00
USD |
OTCM |
May 17, 16:00
Nanobac Pharmaceuticals Max Drawdown (5Y): 99.98% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.98% |
March 31, 2024 | 99.98% |
February 29, 2024 | 99.98% |
January 31, 2024 | 99.98% |
December 31, 2023 | 99.98% |
November 30, 2023 | 99.98% |
October 31, 2023 | 99.98% |
September 30, 2023 | 99.98% |
August 31, 2023 | 99.98% |
July 31, 2023 | 99.98% |
June 30, 2023 | 99.98% |
May 31, 2023 | 99.98% |
April 30, 2023 | 99.98% |
March 31, 2023 | 99.98% |
February 28, 2023 | 99.98% |
January 31, 2023 | 99.98% |
December 31, 2022 | 99.98% |
November 30, 2022 | 99.98% |
October 31, 2022 | 99.98% |
September 30, 2022 | 99.98% |
August 31, 2022 | 99.98% |
July 31, 2022 | 99.98% |
June 30, 2022 | 99.98% |
May 31, 2022 | 99.98% |
April 30, 2022 | 99.98% |
Date | Value |
---|---|
March 31, 2022 | 99.98% |
February 28, 2022 | 99.98% |
January 31, 2022 | 99.98% |
December 31, 2021 | 99.98% |
November 30, 2021 | 99.98% |
October 31, 2021 | 99.98% |
September 30, 2021 | 95.00% |
August 31, 2021 | 95.00% |
July 31, 2021 | 95.00% |
June 30, 2021 | 95.00% |
May 31, 2021 | 95.00% |
April 30, 2021 | 94.44% |
March 31, 2021 | 94.44% |
February 28, 2021 | 94.44% |
January 31, 2021 | 94.44% |
December 31, 2020 | 95.83% |
November 30, 2020 | 95.83% |
October 31, 2020 | 95.83% |
September 30, 2020 | 95.83% |
August 31, 2020 | 96.88% |
July 31, 2020 | 97.30% |
June 30, 2020 | 97.30% |
May 31, 2020 | 97.30% |
April 30, 2020 | 97.30% |
March 31, 2020 | 97.30% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.44%
Minimum
Jan 2021
99.98%
Maximum
Oct 2021
98.19%
Average
99.98%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Theriva Biologics Inc | 99.81% |
Oragenics Inc | 98.92% |